Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2010
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2010
Report date:
2010

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
Qualifier:
according to guideline
Guideline:
EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
GLP compliance:
yes (incl. QA statement)
Type of study:
mouse local lymph node assay (LLNA)

Test material

Constituent 1
Chemical structure
Reference substance name:
Zinc bis(dihydrogen phosphate)
EC Number:
237-067-2
EC Name:
Zinc bis(dihydrogen phosphate)
Cas Number:
13598-37-3
Molecular formula:
Zn(H2PO4)2
IUPAC Name:
zinc bis(dihydrogen phosphate)
Test material form:
solid: particulate/powder
Remarks:
migrated information: powder
Details on test material:
- Name of test material (as cited in study report): Zinc bis(dihydrogen phosphate)
- Physical state: white crystalline solid powder
- Analytical purity: ZnO(%): 25-27 P2O5(%): 43-49.5
- Composition of test material, percentage of components: Zinc bis(dihydroogen phosphate)*2H2O : phosphate (as P2O5) 44.6% ±5% rel.; Zinc: 21.5%±0.5 % rel.
- Lot/batch No.: Z 11-81
- Stability / expiration: 31.08.2011
- Storage condition of test material: in dark at the ambient temperature in the original container

In vivo test system

Test animals

Species:
mouse
Strain:
Balb/c
Sex:
female
Details on test animals and environmental conditions:
TEST ANIMALS
- Source: Breeding farm VELAZ s.r.o., Kolec u Kladna, Czech Republic
- Age at study initiation: 8-10 weeks
- Weight at study initiation: 18.7-21.7g
- Housing: maximum six in macrolon cages (35X20X15cm) with sterilized softwood shavings
- Diet: pelleted standard diet for experimental animals ad libitum (ST1 BERGMAN)
- Water: drinking tap water ad libitum
- Acclimation period: at least 5 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22.5-23.4
- Humidity (%): 41-48
- Photoperiod (hrs dark / hrs light): 12/12

Study design: in vivo (LLNA)

Vehicle:
other: DAE 433 (mixture of 40% dimethylacetamide, 30% acetone and 30% ethanol)
Concentration:
30%, 3%, 0.3% (w/v)
No. of animals per dose:
5
Details on study design:
RANGE FINDING TESTS:
in pilot experiment, the highest concentration 30% (maximum technically practicable concentration) was administered to 3 animals to assess and/or discard a possible systemic toxicity or high irritation of skin. The route of administration was the same as in the main study. During the pilot experiment no test item related effects were found in all three animals, respectively no clinical symptoms of systemic toxicity and no macroscopic changes (after necropsy) were detected.

MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: LLNA
- Criteria used to consider a positive response: if the simulation index (SI) is ≥3 , and the response increases in dose-related manner (dose-response relationship)
- dosage volume: 25µl/ear /animal

TREATMENT PREPARATION AND ADMINISTRATION:
all suspensions were prepared by mixing an appropriate amount of zinc bis(dihydrogen phosphate) (1.5g, 0.15g or 0.015g) and the vehicle to obtain the application form (3X5mL) in concentration of 30%, 3% or 0.3% (w/v). The suspensions were prepared before the start of application by mixing on mangetic stirrer and then were still mixed during application. Suspensions were prepared on each day immediately before administration (10-20min)
Positive control substance(s):
other: dinitrochlorobenzene
Statistics:
Kruskal-Wallis test: for the comparision of the measured effect in all treatment groups with the vehicle control group, as global test
Mann-Whitney test: for all 2-group comparisions

Results and discussion

In vivo (LLNA)

Resultsopen allclose all
Parameter:
SI
Value:
9.29
Test group / Remarks:
positive control
Parameter:
SI
Value:
1
Test group / Remarks:
negative control
Parameter:
SI
Value:
3.13
Test group / Remarks:
30% test substance
Parameter:
SI
Value:
1.09
Test group / Remarks:
3% test substance
Parameter:
SI
Value:
0.69
Test group / Remarks:
0.3% test substance

Any other information on results incl. tables

group   radioisotope incorporation    ear weight 
   mean DPM SI  mean (mg) 
 negative control  799.43 1.00   23.66
positive control   7427.57  9.29+  38.88*
 30%  2503.43  3.13+  26.18*
3%   869.99  1.09  23.52
 0.3%  550.90  0.69 22.78 

*= statistically significant p<0.05 (Mann-Whitney test)

+= values ≥3

Applicant's summary and conclusion

Interpretation of results:
study cannot be used for classification
Remarks:
Test substance had a positive result in LLNA test, but potential irriation effect does not rule out the possibility that it could be false positive result.
Conclusions:
Test substance had a positive result in LLNA test, but potential irriation effect does not rule out the possibility that it could be false positive result.
Executive summary:

The test substance, zinc bis(dihydrogen phosphate) was tested for the assessment of skin sensitisation potential with the murine local lymph node assay.

The local lymph node assay (LLNA) with radionuclides was used. The testing was conducted according to the EU Method B.42, skin sensitization: local lymph node assay. In this study the contact allergenic potential of zinc bis(dihydrogen phosphate) was evaluated after topical application to female BALB/c mice. Five mice per group were exposed on the dorsum of both ears once a day by test and control substances during 3 consecutive days. Primary proliferation of lymphocytes in the lymph node draining the site of application was evaluated on the base on using radioactive labelling. The ratio of the proliferation in treated groups to that in vehicular controls, termed the Stimulation index, was determined. Statistical evaluation of ear weight was performed for elimination of false positive findings with certain skin irritants.

Concentrations: positive control DNCB: 0.5% (w/v) and zinc bis(dihydrogen phosphate): 30%, 3%, 0.3% (w/v) in DAE 433.

The animals exposed to the test substance at all concentrations showed no pathological skin reactions and no other negative clinical symptoms of intoxication throughout the experiment. There was no significant difference in body weight increment of all groups in comparison to the vehicle control. The positive control substance DNCB elicted a reaction pattern with statistically significant increase in ear weight and stimulation index of cell proliferation 9.29, which was in congruence with his expected mode of action as a contact allergen.

The test substance showed a tendency to increased ear weight in the highest of concentrations tested. The result of skin irritation effect was considered as positive- it means the thest substance caused irritation of skin. Comparison of stimulation indexes between treated groups and control group revealed that the test substance caused significant increase in radioisotope incorporation into the DNA of dividing lymphocytes. This effect was dose dependent, with a significant ratio of 3.13 at 30%.

The test substance zinc bis(dihydrogen phosphate) had a positive result in LLNA test. Positive results in cell proliferation and no clinical symptoms of systemic toxicity revealed that the test substance zinc bis(dihydrogen phosphate) could be a contact allergen in mice but potential irriation effect does not rule out the possibility that it could be false positive result.